Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 168

The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.

Endocannabinoids and traumatic brain injury

Open access
Shohami, Esther, Cohen‐Yeshurun, Ayelet, Magid, Lital, Algali, Merav, Mechoulam, Raphael · 2011 · British Journal of Pharmacology

Abstract

Traumatic brain injury (TBI) represents the leading cause of death in young individuals. It triggers the accumulation of harmful mediators, leading to secondary damage, yet protective mechanisms are also set in motion. The endocannabinoid (eCB) system consists of ligands, such as anandamide and 2‐arachidonoyl‐glycerol (2‐AG), receptors (e.g. CB1, CB2), transporters and enzymes, which are responsible for the ‘on‐demand’ synthesis and degradation of these lipid mediators. There is a large body of evidence showing that eCB are markedly increased in response to pathogenic events. This fact, as well as numerous studies on experimental models of brain toxicity, neuroinflammation and trauma supports the notion that the eCB are part of the brain's compensatory or repair mechanisms. These are mediated via CB receptors signalling pathways that are linked to neuronal survival and repair. The levels of 2‐AG, the most highly abundant eCB, are significantly elevated after TBI and when administered to TBI mice, 2‐AG decreases brain oedema, inflammation and infarct volume and improves clinical recovery. The role of CB1 in mediating these effects was demonstrated using selective antagonists or CB1 knockout mice. CB2 were shown in other models of brain insults to reduce white blood cell rolling and adhesion, to reduce infarct size and to improve motor function. This review is focused on the role the eCB system plays as a self‐neuroprotective mechanism and its potential as a basis for the development of novel therapeutic modality for the treatment of CNS pathologies with special emphasis on TBI. LINKED ARTICLES This article is part of a themed issue on Cannabinoids in Biology and Medicine. To view the other articles in this issue visit http://dx.doi.org/10.1111/bph.2011.163.issue‐7

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1476-5381.2011.01343.x

Cites

9 of 9 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 9 references

Research works printed but not linked: 80

  1. 10.1096/fj.05-3995fje · DOI · Paper page
  2. 10.1523/JNEUROSCI.3101-05.2006 · DOI · Paper page
  3. 10.1016/S0306-4522(00)00389-4 · DOI · Paper page
  4. Alessandri B, 1996, Application of glutamate in the cortex of rats: a microdialysis study, Acta Neurochir Suppl, 67, 6, 10.1007/978-3-7091-6894-3_2 · doi:10.1007/978-3-7091-6894-3_2
  5. 10.2174/157015907780866884 · DOI · Paper page
  6. 10.1089/neu.1999.16.1165 · DOI
  7. 10.1517/13543784.15.4.351 · DOI
  8. 10.1097/00005344-200036051-00104 · doi:10.1097/00005344-200036051-00104
  9. 10.2174/157015907780866910 · DOI
  10. 10.2119/2008-00050.Beauchamp · DOI · Paper page
  11. 10.1097/00004647-199703000-00004 · DOI
  12. 10.1096/fj.03-0323fje · DOI · Paper page
  13. 10.1523/JNEUROSCI.3923-04.2005 · DOI · Paper page
  14. 10.1038/sj.bjp.0707505 · DOI · Paper page
  15. 10.1002/(SICI)1098-2396(19990901)33:3<181::AID-SYN3>3.0.CO;2-R · DOI · Paper page
  16. 10.1006/bbrc.1999.0254 · DOI · Paper page
  17. 10.1089/neu.1998.15.253 · DOI
  18. 10.1189/jlb.0405216 · DOI · Paper page
  19. 10.1124/mol.65.4.999 · DOI · Paper page
  20. 10.1038/39807 · DOI · Paper page
  21. 10.1093/brain/awm160 · DOI · Paper page
  22. 10.1097/00004647-200101000-00002 · DOI · Paper page
  23. 10.1097/00004647-199902000-00003 · doi:10.1097/00004647-199902000-00003
  24. 10.1161/01.RES.87.4.323 · DOI
  25. 10.1161/01.CIR.92.11.3337 · DOI · Paper page
  26. 10.1002/syn.20547 · DOI
  27. 10.1073/pnas.161191698 · DOI · Paper page
  28. 10.1126/science.1470919 · DOI · Paper page
  29. 10.1016/S0165-6147(00)01712-0 · DOI · Paper page
  30. Ehrhart J, 2005, Stimulation of cannabinoid receptor 2 (CB2) suppresses microglial activation, J Neuroinflammation, 12, 2
  31. 10.1016/S0300-9572(00)00321-X · DOI · Paper page
  32. 10.1016/S0014-2999(03)02074-0 · DOI
  33. 10.1016/S0014-2999(00)00653-1 · DOI · Paper page
  34. 10.1124/mol.62.6.1385 · DOI · Paper page
  35. 10.1177/1073858406296407 · DOI
  36. 10.1523/JNEUROSCI.5693-09.2010 · DOI · Paper page
  37. 10.1016/j.brainres.2006.03.011 · DOI
  38. 10.1016/j.molbrainres.2004.08.025 · DOI · Paper page
  39. 10.1046/j.1460-9568.2000.00217.x · DOI · Paper page
  40. 10.1016/S0306-4522(01)00287-1 · DOI · Paper page
  41. 10.1089/neu.1988.5.259 · DOI · Paper page
  42. 10.1016/j.lfs.2009.06.003 · DOI
  43. 10.1016/S1474-4422(08)70165-0 · DOI · Paper page
  44. 10.1523/JNEUROSCI.2347-05.2005 · DOI
  45. 10.1038/sj.embor.7400234 · DOI · Paper page
  46. Koch M, 2010, The cannabinoid WIN 55,212‐2‐mediated protection of dentate gyrus granule cells is driven by CB1 receptors and modulated by TRPA1 and Cav2.2 channels, Hippocampus
  47. 10.1016/S0165-0173(02)00157-1 · DOI · Paper page
  48. 10.1097/00019052-199412000-00007 · doi:10.1097/00019052-199412000-00007
  49. 10.1146/annurev.pharmtox.46.120604.141254 · DOI · Paper page
  50. 10.1186/1471-2202-11-44 · DOI · Paper page
  51. 10.1111/j.1471-4159.2005.03380.x · DOI · Paper page
  52. 10.1126/science.1088208 · DOI · Paper page
  53. 10.1016/S0014-2999(98)00777-8 · DOI
  54. 10.1073/pnas.0510676103 · DOI · Paper page
  55. 10.1523/JNEUROSCI.19-08-02987.1999 · DOI · Paper page
  56. 10.1016/S0074-7742(09)88012-4 · DOI
  57. 10.1111/j.1471-4159.2007.04642.x · DOI · Paper page
  58. 10.1096/fj.06-6164fje · DOI · Paper page
  59. 10.1074/jbc.M707960200 · DOI · Paper page
  60. 10.1038/35097089 · DOI · Paper page
  61. 10.1038/sj.jcbfm.9600047 · DOI · Paper page
  62. 10.1016/j.nbd.2005.11.004 · DOI · Paper page
  63. 10.1111/j.1369-1600.2008.00108.x · DOI · Paper page
  64. 10.1006/nbdi.1998.0221 · DOI · Paper page
  65. 10.1016/S0165-6147(97)01161-9 · DOI
  66. 10.1016/S0165-6147(00)01805-8 · DOI · Paper page
  67. 10.1523/JNEUROSCI.20-01-00051.2000 · DOI
  68. 10.1124/mol.54.3.459 · DOI · Paper page
  69. 10.1523/JNEUROSCI.16-14-04322.1996 · DOI · Paper page
  70. 10.1016/S0165-5728(96)00181-6 · DOI · Paper page
  71. 10.1016/S1359-6101(99)00008-8 · DOI · Paper page
  72. 10.1016/S0304-3940(99)00922-2 · DOI · Paper page
  73. 10.1155/2008/538141 · DOI
  74. 10.1002/glia.20983 · DOI · Paper page
  75. 10.1602/neurorx.1.1.71 · DOI
  76. 10.1096/fasebj.12.11.1035 · DOI · Paper page
  77. 10.1016/j.nurt.2008.10.036 · DOI · Paper page
  78. 10.1038/sj.jcbfm.9600447 · DOI · Paper page
  79. 10.1007/s11481-009-9148-4 · DOI
  80. 10.1016/j.nurt.2009.10.016 · DOI · Paper page

Cited by

See all 168

Metadata

Authors
Shohami, E., Cohen‐Yeshurun, A., Magid, L., Algali, M., & Mechoulam, R.
Venue
British Journal of Pharmacology
Publisher
Wiley
Published
2011-07-12
Volume
163
Issue
7
Pages
1402-1410
ISSN
  • 0007-1188 (ISSN-L)
  • 1476-5381
OpenAlex
W2142460361
Cited by
168
References
9
FWCI
7.30
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Endocannabinoids and traumatic brain injury. https://app.cochat.ai/papers/10.1111/j.1476-5381.2011.01343.x
The paper
Shohami, E., Cohen‐Yeshurun, A., Magid, L., Algali, M., & Mechoulam, R. (2011). Endocannabinoids and traumatic brain injury. British Journal of Pharmacology. https://doi.org/10.1111/j.1476-5381.2011.01343.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.